Target intelligence / Profile preview

ZNF217 antisense RNA 1 (ZNF217-AS1)

Target
ZNF217-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ZNF217 antisense RNA 1 (ZNF217-AS1) is a long non-coding RNA transcribed in the antisense direction relative to the ZNF217 gene. While it does not encode a protein, antisense lncRNAs such as ZNF217-AS1 are implicated in regulating their sense gene’s expression via mechanisms including chromatin remodeling, mRNA stabilization, and epigenetic modification. There is currently limited information specific to ZNF217-AS1's precise biological role or disease association; however, its location and class suggest it may modulate pathways involved in cancer biology by regulating the ZNF217 oncogene[2][5][7][8]. No drugs, biomarker roles, or direct clinical applications have been established for ZNF217-AS1.

02

Mechanism of action

General mechanisms involve RNA-RNA interactions and recruitment of epigenetic modifiers, based on class.

03

Biological functions

Regulation of gene expression (likely impacts its sense gene ZNF217 via antisense mechanisms)Epigenetic regulation (by analogy with known antisense lncRNAs; recruits chromatin modifiers or impacts mRNA stability)
04

Disease associations

Possible involvement in cancer and cell proliferation, inferred from related antisense lncRNAs and the oncogenic role of the sense gene ZNF217; not specifically demonstrated for ZNF217-AS1

Beyond the preview

Go deeper on ZNF217 antisense RNA 1 (ZNF217-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF217 antisense RNA 1 (ZNF217-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call